These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 36337053)
1. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension. Díaz Del Campo LS; García-Redondo AB; Rodríguez C; Zaragoza C; Duro-Sánchez S; Palmas F; de Benito-Bueno A; Socuéllamos PG; Peraza DA; Rodrigues-Díez R; Valenzuela C; Dalli J; Salaices M; Briones AM Hypertension; 2023 Jan; 80(1):84-96. PubMed ID: 36337053 [TBL] [Abstract][Full Text] [Related]
2. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors. Rodrigues-Diez R; Ballesteros-Martinez C; Moreno-Carriles RM; Nistal F; Díaz Del Campo LS; Cachofeiro V; Dalli J; García-Redondo AB; Redondo JM; Salaices M; Briones AM Biomed Pharmacother; 2024 May; 174():116564. PubMed ID: 38608525 [TBL] [Abstract][Full Text] [Related]
3. Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling. Olsen MB; Louwe MC; Yang K; Øgaard J; Dahl TB; Gregersen I; Alfsnes K; Lauritzen KH; Murphy SL; Ahmed MS; Aukrust P; Vinge LE; Yndestad A; Holven KB; Halvorsen B; Fosshaug LE Biochem Biophys Res Commun; 2024 Nov; 733():150706. PubMed ID: 39305571 [TBL] [Abstract][Full Text] [Related]
4. Resolution of inflammation is disturbed in acute ischemic stroke with diabetes mellitus and rescued by resolvin D2 treatment. Tang X; Liu L; Miao Z; Zhang J; Cai X; Zhao BQ; Chen G; Schultzberg M; Zhao Y; Wang X Free Radic Biol Med; 2022 Aug; 188():194-205. PubMed ID: 35750271 [TBL] [Abstract][Full Text] [Related]
5. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization. Pope NH; Salmon M; Davis JP; Chatterjee A; Su G; Conte MS; Ailawadi G; Upchurch GR FASEB J; 2016 Dec; 30(12):4192-4201. PubMed ID: 27619672 [TBL] [Abstract][Full Text] [Related]
6. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II. Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833 [TBL] [Abstract][Full Text] [Related]
7. Resolvin E1/ChemR23 Protects Against Hypertension and Vascular Remodeling in Angiotensin II-Induced Hypertensive Mice. Zhang J; Yin Z; Xu Y; Wei C; Peng S; Zhao M; Liu J; Xu S; Pan W; Zheng Z; Liu S; Ye J; Qin JJ; Wan J; Wang M Hypertension; 2023 Dec; 80(12):2650-2664. PubMed ID: 37800344 [TBL] [Abstract][Full Text] [Related]
10. Bortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats. Li S; Wang X; Li Y; Kost CK; Martin DS PLoS One; 2013; 8(10):e78564. PubMed ID: 24205262 [TBL] [Abstract][Full Text] [Related]
11. Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5. Romero M; Jiménez R; Toral M; León-Gómez E; Gómez-Gúzman M; Sánchez M; Zarzuelo MJ; Rodríguez-Gómez I; Rath G; Tamargo J; Pérez-Vizcaíno F; Dessy C; Duarte J J Pharmacol Exp Ther; 2016 Jul; 358(1):151-63. PubMed ID: 27189971 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II. Forrester SJ; Elliott KJ; Kawai T; Obama T; Boyer MJ; Preston KJ; Yan Z; Eguchi S; Rizzo V Hypertension; 2017 Jan; 69(1):79-86. PubMed ID: 27895190 [TBL] [Abstract][Full Text] [Related]
13. Resolvin D2 induces anti-microbial mechanisms in a model of infectious peritonitis and secondary lung infection. Sundarasivarao PYK; Walker JM; Rodriguez A; Spur BW; Yin K Front Immunol; 2022; 13():1011944. PubMed ID: 36532055 [TBL] [Abstract][Full Text] [Related]
14. K Olivencia MA; Martínez-Casales M; Peraza DA; García-Redondo AB; Mondéjar-Parreño G; Hernanz R; Salaices M; Cogolludo A; Pennington MW; Valenzuela C; Briones AM Br J Pharmacol; 2021 Apr; 178(8):1836-1854. PubMed ID: 33556997 [TBL] [Abstract][Full Text] [Related]
15. Macrophage depletion protects against endothelial dysfunction and cardiac remodeling in angiotensin II hypertensive mice. Tian Y; Luo J; Xu Q; Liu Y; Cai R; Zhou MS Clin Exp Hypertens; 2021 Nov; 43(8):699-706. PubMed ID: 34176379 [No Abstract] [Full Text] [Related]
16. Resolvin-D1 attenuation of angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension. Olivares-Silva F; De Gregorio N; Espitia-Corredor J; Espinoza C; Vivar R; Silva D; Osorio JM; Lavandero S; Peiró C; Sánchez-Ferrer C; Díaz-Araya G Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166241. PubMed ID: 34400298 [TBL] [Abstract][Full Text] [Related]
17. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. Akagi D; Chen M; Toy R; Chatterjee A; Conte MS FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995 [TBL] [Abstract][Full Text] [Related]
19. Differential Expression of Hypertensive Phenotypes in BXD Mouse Strains in Response to Angiotensin II. Zhao W; Zhao T; Chen Y; Bhattacharya SK; Lu L; Sun Y Am J Hypertens; 2017 Dec; 31(1):108-114. PubMed ID: 29036574 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice. Gao P; Xu TT; Lu J; Li L; Xu J; Hao DL; Chen HZ; Liu DP J Mol Med (Berl); 2014 Apr; 92(4):347-57. PubMed ID: 24352856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]